RecruitingPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Sponsor: H. Lundbeck A/S
Amherst, NY · Commack, NY · +20 more sites
Clinical trials in Amherst, NY
22 recruiting studies have a site in or near Amherst, NY, New York.
Top conditions here
- Migraine (12)
- Depression (3)
- Parkinson's Disease (2)
- Type 2 Diabetes (2)
- Obesity (2)
- Multiple Sclerosis (1)
- Alzheimer's Disease (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 22 of 22 studies
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
RecruitingPhase 3NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Sponsor: Pfizer
Amherst, NY · The Bronx, NY · +54 more sites
RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
Amherst, NY · Commack, NY · +18 more sites
RecruitingPhase 2NCT06656416
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Sponsor: Alto Neuroscience
Amherst, NY · New York, NY · +56 more sites
RecruitingPhase 3NCT06810505
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Sponsor: AbbVie
Amherst, NY · +31 more sites
RecruitingPhase 3NCT06976203
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Sponsor: Bristol-Myers Squibb
Albany, NY · Amherst, NY · Buffalo, NY · +28 more sites
RecruitingPhase 2NCT07589608
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Amherst, NY · Rochester, NY · +38 more sites
RecruitingPhase 2NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Sponsor: Eli Lilly and Company
Amherst, NY · East Syracuse, NY · Port Jefferson Station, NY · +47 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Amherst, NY · New York, NY · +40 more sites
RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Amherst, NY · Commack, NY · New York, NY · +50 more sites
RecruitingNot applicableNCT06959277
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Sponsor: RxFunction Inc.
Amherst, NY · +5 more sites
RecruitingPhase 2NCT07616128
Study of EVO756 in Adults With Migraine
Sponsor: Evommune, Inc.
Amherst, NY · +32 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Amherst, NY · Commack, NY · Great Neck, NY · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Amherst, NY · Commack, NY · New York, NY · +112 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Amherst, NY · New York, NY · +107 more sites
RecruitingNot applicableNCT05889624
Responding With Evidence and Access for Childhood Headaches
Sponsor: Children's Hospital Medical Center, Cincinnati
Amherst, NY · +14 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Amherst, NY · Mount Kisco, NY · New York, NY · +122 more sites
RecruitingPhase 2NCT07804615
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Sponsor: Vima Therapeutics
Amherst, NY · New York, NY · Patchogue, NY · +26 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
RecruitingNot applicableNCT03887715
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Sponsor: LivaNova
Amherst, NY · Buffalo, NY · Lewiston, NY · +98 more sites
RecruitingPhase 2NCT07553637
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Sponsor: Alto Neuroscience
Amherst, NY · Cedarhurst, NY · Lewiston, NY · +35 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.